Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
41.94
-1.84 (-4.20%)
At close: Mar 9, 2026

SHE:301281 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Cash & Equivalents
74.83178.13325.22148.9766.0137.44
Upgrade
Short-Term Investments
--210.26---
Upgrade
Trading Asset Securities
251.91254.43150.54---
Upgrade
Cash & Short-Term Investments
326.74432.56686.02148.9766.0137.44
Upgrade
Cash Growth
-28.03%-36.95%360.50%125.69%76.29%10.48%
Upgrade
Accounts Receivable
99.8995.8575.8556.8743.7166.39
Upgrade
Other Receivables
15.3327.110.650.310.690.54
Upgrade
Receivables
115.23122.9676.557.1844.466.93
Upgrade
Inventory
151.08128.94108.0567.9286.4470.95
Upgrade
Other Current Assets
40.226.268.228.26.531.37
Upgrade
Total Current Assets
633.27690.73878.79282.27203.38176.7
Upgrade
Property, Plant & Equipment
569.03477314.2308.83290.27217.61
Upgrade
Long-Term Investments
192.61190.31184.08---
Upgrade
Goodwill
1.821.82----
Upgrade
Other Intangible Assets
114.47107.1746.0249.0851.7654.76
Upgrade
Long-Term Deferred Tax Assets
3.343.062.922.091.621.69
Upgrade
Long-Term Deferred Charges
3.032.390.731.733.154.45
Upgrade
Other Long-Term Assets
88.2779.9843.227.799.343.33
Upgrade
Total Assets
1,6061,5521,470651.79559.51458.53
Upgrade
Accounts Payable
47.5242.2550.1854.9860.5828.89
Upgrade
Accrued Expenses
12.6844.5939.7129.2323.6524.9
Upgrade
Current Income Taxes Payable
4.141.080-4.597.98
Upgrade
Current Unearned Revenue
3.920.243.53.023.0912.75
Upgrade
Other Current Liabilities
44.3111.6317.7520.6418.8325.26
Upgrade
Total Current Liabilities
112.55119.78111.14107.86110.7599.79
Upgrade
Long-Term Debt
97.5845.66----
Upgrade
Long-Term Unearned Revenue
9.159.2710.539.0410.1110.39
Upgrade
Long-Term Deferred Tax Liabilities
15.1217.7817.2515.167.666.72
Upgrade
Other Long-Term Liabilities
-0.38----
Upgrade
Total Liabilities
234.4192.87138.93132.06128.52116.9
Upgrade
Common Stock
108.29108.29108.29585858
Upgrade
Additional Paid-In Capital
907.67907.67909.97195.34195.34186.45
Upgrade
Retained Earnings
350.08340.26312.3266.2174.9396.75
Upgrade
Comprehensive Income & Other
4.812.570.480.192.720.43
Upgrade
Total Common Equity
1,3711,3591,331519.73430.98341.63
Upgrade
Minority Interest
0.60.81----
Upgrade
Shareholders' Equity
1,3711,3601,331519.73430.98341.63
Upgrade
Total Liabilities & Equity
1,6061,5521,470651.79559.51458.53
Upgrade
Total Debt
97.5845.66----
Upgrade
Net Cash (Debt)
229.16386.9686.02148.9766.0137.44
Upgrade
Net Cash Growth
-49.52%-43.60%360.50%125.69%76.29%-
Upgrade
Net Cash Per Share
2.133.596.771.830.810.46
Upgrade
Filing Date Shares Outstanding
108.29108.29108.2981.281.281.2
Upgrade
Total Common Shares Outstanding
108.29108.29108.2981.281.281.2
Upgrade
Working Capital
520.73570.95767.65174.492.6476.91
Upgrade
Book Value Per Share
12.6612.5512.296.405.314.21
Upgrade
Tangible Book Value
1,2551,2501,285470.65379.23286.88
Upgrade
Tangible Book Value Per Share
11.5911.5411.875.804.673.53
Upgrade
Buildings
-216.15213.26208.05186.34152.37
Upgrade
Machinery
-342.54316.21275.82210.37193.11
Upgrade
Construction In Progress
-183.1512.1519.9966.2322.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.